Harrow, Inc. APIC, Share-based Payment Arrangement, Recognition and Exercise
Harrow, Inc. (HROW) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of $23.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-21.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2017-03-21
- Harrow, Inc. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2016-12-31 was $0.00.
- Harrow, Inc. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2016-09-30 was $0.00.
- Harrow, Inc. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2016-06-30 was $0.00.
- Harrow, Inc. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2016-03-31 was $23.00K, a 41.03% decline year-over-year.
- Harrow, Inc. apic, share-based payment arrangement, recognition and exercise for fiscal 2016 was $23.00K, a 41.03% decline from fiscal 2015.
- Harrow, Inc. apic, share-based payment arrangement, recognition and exercise for fiscal 2015 was $39.00K.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 9 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $0.00 derived: sum of 2 quarters · filed 2017-03-21 | $0.00 derived: sum of 3 quarters · filed 2017-03-21 | $23.00K 10-K · filed 2017-03-21 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $23.00K 10-Q · filed 2016-11-14 | $23.00K derived: sum of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $23.00K 10-Q · filed 2016-08-15 | $23.00K derived: sum of 3 quarters · filed 2016-08-15 | $23.00K derived: sum of 4 quarters · filed 2016-08-15 |
| 2016-03-31 | $23.00K 10-Q · filed 2016-05-12 | $23.00K derived: sum of 2 quarters · filed 2016-05-12 | $23.00K derived: sum of 3 quarters · filed 2016-05-12 | $23.00K derived: sum of 4 quarters · filed 2016-05-12 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $0.00 derived: sum of 2 quarters · filed 2016-03-23 | $0.00 derived: sum of 3 quarters · filed 2016-03-23 | $39.00K 10-K · filed 2016-03-23 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $0.00 derived: sum of 2 quarters · filed 2015-11-12 | $39.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $39.00K 10-Q · filed 2015-08-12 | ||
| 2015-03-31 | $39.00K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |